Sparcl1通过抑制淋巴血管生成介导的TLS形成来缓解腹腔大动脉动脉瘤
Mei-Hua Chen1, Yi-Jie Hua2, Yan Li3
1Institute of Metabolism and Regenerative Medicine, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Centre for Diabetes, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Nature immunology
|February 27, 2026
概括
分泌Sparcl1的血管巨细胞可以预防腹腔大动脉动脉瘤 (AAA). 失去Sparcl1通过促进异常淋巴血管生成和淋巴状结构来加速AAA,但Sparcl1衍生的显示出治疗前景.
科学领域:
- 免疫学 免疫学 免疫学
- 血管生物学 血管生物学
- 生物化学 生物化学
背景情况:
- 血管组织居民巨细胞 (VRMs) 对于血管免疫恒温至关重要.
- 在腹腔大动脉动脉瘤 (AAA) 的发病过程中VRMs的具体作用尚不清楚.
研究的目的:
- 在AAA开发中调查特定VRM子集的功能.
- 阐明这些VRM使用的保护机制.
- 探索针对这种途径的潜在治疗策略.
主要方法:
- 在AAA模型中分析VRM.
- 在VRMs中遗传删除Sparcl1 (Sc1).
- 对淋巴血管生成和三级淋巴体结构 (TLSs) 的评估.
- 对Sc1-FGF2相互作用的研究.
- 在AAA模型中评估治疗性 (Spa17).
主要成果:
- 在adventitia中的Lyve1+VRMs分泌Sparcl1 (Sc1),从而提供对AAA的保护.
- 在VRMs中Sc1缺乏导致功能障碍的淋巴血管生成和TLS形成,加速AAA的进展.
- Sc1与FGF2结合,抑制FGF2驱动的淋巴血管生成和TLS基因表达.
- 在实验模型中,治疗性Spa17有效地减轻了AAA的进展.
结论:
- 在AAA中,VRM衍生的Sc1起着关键的保护作用.
- Sc1的机制涉及抑制FGF2介导的病理过程.
- Sc1及其衍生品代表了AAA治疗的有前途的治疗途径.
相关概念视频
Aneurysm III: Interprofessional Care
403
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
403
Peripheral Artery Disease I: Introduction
490
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
490
Atherosclerosis I: Introduction
1.6K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.6K
Peripheral Artery Disease III: Interprofessional Care
443
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
443
Aneurysm II: Clinical Manifestations and Diagnostic Studies
441
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
441


